Clinical Trial Update: Olmesartan Medoxomil in Hypertension and Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of a study evaluating olmesartan medoxomil in patients with essential hypertension and renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Renal Impairment

Drugs mentioned

• BENICAR (OLMESARTAN MEDOXOMIL)
• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Sankyo Pharma Gmbh | Conditions: Essential Hypertension, Renal Impairment | Phase 3 | Status: COMPLETED